Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

GLP-1 receptor agonists in obstructive sleep apnea: A propensity score-matched real-world analysis.

Respiratory medicine·2026
Same author

Neuro-ophthalmic complications of tuberculosis and its treatment: a systematic review and meta-analysis.

Frontiers in ophthalmology·2026
Same author

Revolutionizing medical physiology education: a narrative review of the transition from traditional classrooms to artificial intelligence.

Frontiers in medicine·2026
Same author

Efficacy and Safety of Deutetrabenazine in Tourette Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Psychopharmacology bulletin·2026
Same author

Efficacy and Safety of Centanafadine in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Psychopharmacology bulletin·2026
Same author

Movement Disorders Associated With Breast Cancer: A Systematic Review.

Annals of Indian Academy of Neurology·2026
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarcadores

Muneeb Ahmad Muneer1, Harshita Agarwal2, Poorvikha Gowda3

  • 1Allama Iqbal Medical College, Lahore, Punjab, Pakistan.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Este meta-análisis revela reducciones significativas de serotonina, dopamina y norepinefrina en regiones cerebrales específicas de pacientes con enfermedad de Alzheimer (EA). Estos cambios de neurotransmisores pueden servir como biomarcadores diagnósticos tempranos para la EA.

Palabras clave:
BiomarcadoresEnfermedad de AlzheimerNeurotransmisoresSerotoninaDopaminaNorepinefrinaDiagnósticoMeta-análisis

Más Videos Relacionados

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Área de la Ciencia:

  • Neurociencia; Bioquímica; Biomarcadores Médicos

Sus antecedentes:

  • La enfermedad de Alzheimer (EA) se caracteriza por neuroinflamación, deterioro vascular y disfunción sináptica.; La investigación de los niveles de neurotransmisores ofrece potencial para el diagnóstico temprano de la EA.

Objetivo del estudio:

  • Evaluar y comparar los niveles de dopamina, serotonina y norepinefrina en regiones cerebrales de pacientes con EA frente a controles sanos.; Explorar el potencial de estos neurotransmisores como biomarcadores diagnósticos tempranos para la EA.

Principales métodos:

  • Se realizó una búsqueda sistemática de literatura en MEDLINE, EMBASE, Cochrane y Scopus, siguiendo las directrices PRISMA.; Se realizó un meta-análisis utilizando el paquete 'meta' de R para calcular las diferencias de medias estandarizadas (DME) y evaluar la heterogeneidad.

Principales resultados:

  • Se observaron reducciones significativas de serotonina en múltiples regiones cerebrales, particularmente en el hipocampo (DME: -2.53).; Los niveles de dopamina disminuyeron notablemente en las regiones frontal y temporal (DME general: -0.55).; La norepinefrina mostró reducciones sustanciales, especialmente en las regiones del hipocampo y frontal (DME general: -1.84).

Conclusiones:

  • La serotonina, la dopamina y la norepinefrina se agotan significativamente en áreas cerebrales específicas en la enfermedad de Alzheimer.; Estas alteraciones de neurotransmisores resaltan su potencial como biomarcadores diagnósticos para la EA.; Se necesita más investigación para validar estos hallazgos.